TipRanks
Carbios SA (FR:ALCRB)
:ALCRB
Want to see FR:ALCRB full AI Analyst Report?

Carbios SA (ALCRB) AI Stock Analysis

20 Followers

Top Page

FR:ALCRB

Carbios SA

(ALCRB)

Select Model
Select Model
Select Model
Neutral 50 (OpenAI - Gpt-5.6Sol)
Rating:50Neutral
Price Target:
€5.50
▼(-14.73% Downside)
Action:Reiterated
Date:07/24/26
The score is held back primarily by persistent large operating losses and ongoing negative operating/free cash flow despite strong revenue growth. A comparatively well-capitalized, low-debt balance sheet provides meaningful support, while technicals show only moderate improvement (near-term strength but longer-term downtrend) and valuation is difficult to justify due to negative earnings and no dividend.
Positive Factors
Proprietary enzymatic recycling technology
The proprietary enzymatic process addresses a structural need for circular PET recycling by converting waste into monomers suitable for recycled PET with virgin-like properties. If industrialized successfully, this technology could support licensing, partnerships, and recurring adoption across packaging and textiles.
Negative Factors
Persistent large operating losses
Large operating and net losses show that the current business remains far from self-sustaining financially. Unless commercialization produces substantially higher revenue and margins, continued losses can erode equity, constrain investment capacity, and delay the realization of the technology’s long-term potential.
Read all positive and negative factors
Positive Factors
Negative Factors
Proprietary enzymatic recycling technology
The proprietary enzymatic process addresses a structural need for circular PET recycling by converting waste into monomers suitable for recycled PET with virgin-like properties. If industrialized successfully, this technology could support licensing, partnerships, and recurring adoption across packaging and textiles.
Read all positive factors

Carbios SA (ALCRB) vs. iShares MSCI France ETF (EWQ)

Carbios SA Business Overview & Revenue Model

Company Description
Carbios SAS, a pioneering French green chemistry company, is at the forefront of developing industrial bioprocesses for the biodegradation and biorecycling of various polymers. Among its key innovations is EVANESTO, an enzymatic solution specifica...
How the Company Makes Money
Carbios generates (or aims to generate, as technologies are scaled) revenue primarily by monetizing its proprietary enzymatic recycling technologies and associated know-how. Key revenue streams include: (1) Licensing and royalties: Carbios can lic...

Carbios SA Financial Statement Overview

Summary
Despite sharp 2025 revenue growth (~+433% to ~€3.1M), profitability remains very weak (gross profit deeply negative; EBIT ~-€25.9M; net loss ~-€34.3M) and cash flow is still meaningfully negative (operating CF ~-€15.7M; FCF ~-€18.4M). The main offset is a relatively strong, low-leverage balance sheet (equity ~€193.8M vs debt ~€7.5M), but ongoing losses and cash burn keep the financial profile below average.
Income Statement
22
Negative
Balance Sheet
66
Positive
Cash Flow
28
Negative
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue3.10M136.00K24.00K70.00K105.00K
Gross Profit-16.56M96.00K24.00K70.00K105.00K
EBITDA-21.40M-32.29M-18.73M-20.73M5.29M
Net Income-34.26M-33.11M-27.22M-27.74M3.78M
Balance Sheet
Total Assets232.49M279.98M302.01M183.96M178.73M
Cash, Cash Equivalents and Short-Term Investments49.96M93.11M191.82M100.56M104.96M
Total Debt31.65M45.67M48.62M46.01M20.29M
Total Liabilities38.27M80.31M67.69M58.52M32.00M
Stockholders Equity193.76M199.68M234.31M125.44M146.74M
Cash Flow
Free Cash Flow-18.44M-92.76M-49.39M-34.77M-21.25M
Operating Cash Flow-15.65M-30.20M-22.59M-23.05M-9.04M
Investing Cash Flow-18.03M-70.58M-22.39M-9.33M-22.84M
Financing Cash Flow330.00K-1.28M136.25M26.75M107.76M

Carbios SA Technical Analysis

Technical Analysis Sentiment
Negative
Last Price6.45
Price Trends
50DMA
6.31
Negative
100DMA
6.52
Negative
200DMA
8.14
Negative
Market Momentum
MACD
-0.25
Positive
RSI
34.96
Neutral
STOCH
27.21
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:ALCRB, the sentiment is Negative. The current price of 6.45 is above the 20-day moving average (MA) of 6.03, above the 50-day MA of 6.31, and below the 200-day MA of 8.14, indicating a bearish trend. The MACD of -0.25 indicates Positive momentum. The RSI at 34.96 is Neutral, neither overbought nor oversold. The STOCH value of 27.21 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FR:ALCRB.

Carbios SA Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
€106.29B28.4713.42%1.84%-1.30%3.05%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
60
Neutral
€4.31B100.000.92%6.32%-5.73%-73.67%
57
Neutral
€79.63M21.767.97%1.35%6.27%-0.96%
50
Neutral
€94.65M-2.73-18.56%
49
Neutral
€104.12M-5.02-26.54%-20.58%-41.43%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
FR:ALCRB
Carbios SA
5.54
-3.81
-40.75%
FR:AI
Air Liquide
166.24
11.24
7.25%
FR:AKE
Arkema
57.00
2.12
3.87%
FR:ALAFY
AFYREN
2.66
0.13
5.14%
FR:ALBKK
Baikowski SA
22.20
3.43
18.26%
FR:ALDUB
Encres Dubuit SA
2.04
-0.34
-14.29%

Carbios SA Corporate Events

Carbios delays financing timeline but stays committed to Longlaville biorecycling plant
Aug 3, 2026
Carbios has reaffirmed its plan to build a biorecycling plant in Longlaville, France, but says closing the project’s financing will take longer than initially expected. Some banking partners have already secured credit committee approval, re...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 24, 2026